Cabaletta Bio Price To Book vs. Current Ratio

CABA Stock  USD 1.87  0.39  17.26%   
Considering Cabaletta Bio's profitability and operating efficiency indicators, Cabaletta Bio may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Cabaletta Bio's ability to earn profits and add value for shareholders. At present, Cabaletta Bio's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 6.06, whereas Free Cash Flow Yield is forecasted to decline to (0.06).
For Cabaletta Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cabaletta Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cabaletta Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cabaletta Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cabaletta Bio over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.16)
Return On Assets
(0.31)
Return On Equity
(0.48)
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cabaletta Bio Current Ratio vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Cabaletta Bio's current stock value. Our valuation model uses many indicators to compare Cabaletta Bio value to that of its competitors to determine the firm's financial worth.
Cabaletta Bio is rated below average in price to book category among its peers. It is rated fifth in current ratio category among its peers fabricating about  29.01  of Current Ratio per Price To Book. At present, Cabaletta Bio's Current Ratio is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cabaletta Bio's earnings, one of the primary drivers of an investment's value.

Cabaletta Current Ratio vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Cabaletta Bio

P/B

 = 

MV Per Share

BV Per Share

 = 
0.52 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Cabaletta Bio

Current Ratio

 = 

Current Asset

Current Liabilities

 = 
15.22 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).

Cabaletta Current Ratio Comparison

Cabaletta Bio is currently under evaluation in current ratio category among its peers.

Cabaletta Bio Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Cabaletta Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cabaletta Bio will eventually generate negative long term returns. The profitability progress is the general direction of Cabaletta Bio's change in net profit over the period of time. It can combine multiple indicators of Cabaletta Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income39 K41 K
Operating Income-74.7 M-70.9 M
Net Loss-67.7 M-64.3 M
Income Before Tax-67.7 M-64.3 M
Net Loss-47.7 M-45.3 M
Net Loss-67.7 M-64.3 M
Net Interest IncomeM7.3 M
Interest IncomeM7.3 M
Total Other Income Expense NetM7.3 M
Income Tax Expense-1 M-1.1 M
Non Operating Income Net Other1.3 M911.9 K
Change To Netincome6.2 M4.7 M
Net Loss(1.65)(1.74)
Income Quality 0.79  0.61 
Net Income Per E B T 0.88  0.77 

Cabaletta Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Cabaletta Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cabaletta Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cabaletta Bio's important profitability drivers and their relationship over time.

Use Cabaletta Bio in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cabaletta Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabaletta Bio will appreciate offsetting losses from the drop in the long position's value.

Cabaletta Bio Pair Trading

Cabaletta Bio Pair Trading Analysis

The ability to find closely correlated positions to Cabaletta Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cabaletta Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cabaletta Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cabaletta Bio to buy it.
The correlation of Cabaletta Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cabaletta Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cabaletta Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cabaletta Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Cabaletta Bio position

In addition to having Cabaletta Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Wholesale Thematic Idea Now

Wholesale
Wholesale Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Wholesale theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wholesale Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:
Check out Trending Equities.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
To fully project Cabaletta Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Cabaletta Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Cabaletta Bio's income statement, its balance sheet, and the statement of cash flows.
Potential Cabaletta Bio investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Cabaletta Bio investors may work on each financial statement separately, they are all related. The changes in Cabaletta Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cabaletta Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.